Jan 03, 2017 13:02 pm UTC| Business
ATLANTA, Jan. 03, 2017 -- State Bank Financial Corporation (the “Company”) (NASDAQ:STBZ), the holding company for State Bank and Trust Company (“State Bank”), announced today that it has completed its mergers with NBG...
Jan 03, 2017 13:02 pm UTC| Business
ATLANTA, Jan. 03, 2017 -- State Bank Financial Corporation (the “Company”) (NASDAQ:STBZ), the holding company for State Bank and Trust Company (“State Bank”), announced today that it has completed its mergers with NBG...
Jan 03, 2017 13:02 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Jan. 03, 2017 -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a biopharmaceutical company developing meaningful therapies for patients with severe and life-threatening diseases that have been...
Jan 03, 2017 13:02 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Jan. 03, 2017 -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a biopharmaceutical company developing meaningful therapies for patients with severe and life-threatening diseases that have been...
Jan 03, 2017 13:02 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Jan. 03, 2017 -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a biopharmaceutical company developing meaningful therapies for patients with severe and life-threatening diseases that have been...
EndoLogic Acquires Renzapride from Alizyme, plc
Jan 03, 2017 13:02 pm UTC| Business
CLIFTON, N.J., Jan. 03, 2017 -- EndoLogic, a company focused on the development and commercialization of products that treat gastrointestinal diseases, has acquired the worldwide rights to the clinical-stage asset,...
EndoLogic Acquires Renzapride from Alizyme, plc
Jan 03, 2017 13:02 pm UTC| Business
CLIFTON, N.J., Jan. 03, 2017 -- EndoLogic, a company focused on the development and commercialization of products that treat gastrointestinal diseases, has acquired the worldwide rights to the clinical-stage asset,...